)
Iovance Biotherapeutics (IOVA) investor relations material
Iovance Biotherapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting convened virtually with directors, executive officers, and the independent auditor present.
Inspector of Elections confirmed quorum and explained online voting procedures.
Proxy statement and meeting notice distributed to shareholders as of April 15, 2026.
Board and executive committee updates
Election of nominated directors to serve until the 2027 annual meeting approved.
Shareholder proposals
Advisory approval of executive compensation passed.
Annual frequency for future executive compensation votes approved.
Ratification of Ernst & Young LLP as independent auditor for 2026 approved.
Amendment to increase shares in the 2020 Employee Stock Purchase Plan approved.
Amendment to increase authorized common stock from 500M to 650M shares approved.
- AMTAGVI’s rapid growth and strong clinical data drive expansion, with pivotal trials and new therapies advancing.IOVA
Jefferies Global Healthcare Conference 20264 Jun 2026 - Q1 revenue up 45% to $71.4M; net loss narrowed 32% to $79.0M; FY26 guidance $350M–$370M.IOVA
Q1 202613 May 2026 - Board recommends approval of all proposals, including director elections and share increases.IOVA
Proxy filing29 Apr 2026 - Annual meeting seeks approval for director elections, compensation, auditor, and share increases.IOVA
Proxy filing28 Apr 2026 - Annual meeting to vote on directors, compensation, auditor, and share increases, with board support.IOVA
Proxy filing17 Apr 2026 - Strong commercial growth, pipeline progress, and margin gains set up robust 2026 outlook.IOVA
Barclays 28th Annual Global Healthcare Conference11 Mar 2026 - AMTAGVI drives robust growth as pipeline advances toward major milestones in lung and sarcoma.IOVA
TD Cowen 46th Annual Health Care Conference2 Mar 2026 - 61% annual revenue growth, record margins, and major pipeline advances drive strong momentum.IOVA
Q4 202524 Feb 2026 - Achieved $264M revenue in 2025 with strong TIL therapy adoption and expanding pipeline.IOVA
Corporate presentation24 Feb 2026
Next Iovance Biotherapeutics earnings date
Next Iovance Biotherapeutics earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)